 |
|
|
IAC Board of Directors |
|
These dedicated professionals serve as Directors of IAC |
|
|
|
|
|
KELLY L. MOORE, MD, MPH
President and Chief Executive Officer
Kelly L. Moore, MD, MPH, is a leader in national and global vaccine policy and
immunization program implementation. She joined IAC in January 2020 as Associate
Director for Immunization Education and team lead for Ask the Experts. In
January 2021, she became Deputy Director, and succeeded IAC’s retiring founder,
Deborah L. Wexler, MD, in July 2021.
A native of Huntsville, Alabama, Dr. Moore completed undergraduate and medical
degrees with honors at Vanderbilt University, as well as a traveling fellowship.
She earned her master of public health degree at the Harvard School of Public
Health. After completing a clinical internship in pediatrics at the Johns
Hopkins School of Medicine, she joined the Commissioned Corps of the U.S. Public
Health Service as an Epidemic Intelligence Service (EIS) officer with the CDC,
receiving Crisis Response Service Awards and Outstanding Unit Citations for her
work in bioterrorism surveillance and the response to the 2001 anthrax release.
Dr. Moore completed her post-EIS preventive medicine residency through CDC
assigned to the Tennessee Department of Health (TDH), where she remained for 14
years. Her TDH roles included leading state pandemic planning and later
directing the 2009 pandemic vaccine distribution program. She directed the
Tennessee Immunization Program (TIP), leading the state’s Vaccines For Children
program, the immunization information system (TennIIS), and vaccine-preventable
disease surveillance and response, tripling the size of TIP in the process. The
Association of Immunization Managers (AIM) recognized her work with the 2012
Natalie J. Smith, MD Award for excellence in immunization program management and
supported her participation in the 2018 global Advanced Vaccinology (ADVAC)
course for vaccine decision-makers in Annecy, France. Dr. Moore later founded
her own company, The Vaccine Advisor, LLC, to advise public health agencies,
vaccine manufacturers, and other organizations.
Dr. Moore’s work in vaccine policy development has focused on practical
vaccination program operations. She was the first liaison representative of AIM
to CDC’s Advisory Committee on Immunization Practices (ACIP) from 2011 until
2015, when she was appointed an ACIP voting member, chairing four working groups
over the course of her four-year term. Dr. Moore has a special interest in the
quality of clinic-level vaccine storage and handling, founding and chairing
AIM’s Vaccine Storage and Handling Committee from 2006 to 2018. She is a charter
member of the NSF-International Joint Committee on Vaccine Storage, which
produced the first voluntary manufacturing standards for vaccine storage
equipment in the United States. She has been an advisor to the World Health
Organization (WHO) since 2016 in several roles, including as chair of the
Immunization Practices Advisory Committee (IPAC), as a member of the Committee
on Programmatic Suitability for Vaccine Prequalification (PSPQ), and on the
steering committee of the Vaccine Innovation Prioritization Strategy (VIPS)
project led by Gavi. Since 2018 she has collaborated with visionary leaders
through the Sabin-Aspen Vaccine Science and Policy Group, which has published
white papers proposing strategies for tackling the biggest challenges facing the
immunization world today, including creation of a universal influenza vaccine
and the global rise of vaccine hesitancy. |
|
PATRICIA B. HAIRSTON, CPM
Chair of the Board
Pat Hairston has 35 years of experience in engineering, global supply management, logistics, and trade compliance. She is the President of Global Supply Chain Solutions, LLC (GSCS), providing comprehensive
consulting services across all industries. GSCS assist clients in identifying problem areas and improves the end-to-end efficiency in an organization’s supply chain.
Prior to starting Global Supply Chain Solutions, LLC, Pat was a Supply Chain Executive at Corning Incorporated, leading global teams across many countries.
She has worked with senior leaders in corporate America and academia. She moved to Nashville, TN and joined Tennessee State University as an Executive-on-Loan, sponsored by Corning,
and served as the Vice President of Development and University Relations, reporting to the President.
Pat completed the Dartmouth College, Tuck 2020: Global Leadership Executive Education Program, focusing on India and China. She holds a Bachelor of Science degree in Architectural/Civil Engineering
from Tennessee State University.
|
|
CLEMENT LEWIN, PhD, MBA
Treasurer
Clement Lewin is a Principal at CSL Vaccine Consulting focusing medical affairs, policy and strategy after a 25-year career in vaccines. Until the end of 2020 he headed the BARDA Office and
New Vaccine Stakeholder Engagement for Sanofi Pasteur supporting pandemic influenza and COVID-19 vaccine programs. He started at Merck and held several domestic and international positions.
At Chiron Vaccines he served as Vice President, Strategic Planning & Business Intelligence and then Vice President, Government Affairs & Immunization Policy for the US.
At Acambis he headed Government Affairs, Strategic Planning and Marketing playing a key role in licensing ACAM2000, a new smallpox vaccine.
Prior to Sanofi he headed Medical Affairs & Immunization Policy for Novartis North America helping launch several vaccines and responding to the 2009 pandemic.
Clem obtained his BSc and PhD from the University of London. After 5 years as a Research Fellow at the Universities of London and Edinburgh, he obtained an MBA with distinction
from Cornell University and joined the life sciences practice of Pittiglio Rabin Todd & McGrath specializing in product development issues. Clem was the Biotechnology Innovation
Organization liaison to the Advisory Committee on Immunization Practices from 2004 to 2014. He served on the National Vaccine Advisory Committee from 2009-2012.
He currently serves on the Board of Trustees of Gaylord Hospital a long-term acute care facility in Connecticut.
|
|
KATHRYN M. EDWARDS, MD
Director
Dr. Edwards, the Sarah H. Sell and Cornelius Vanderbilt Professor of Pediatrics at Vanderbilt University in Nashville, TN, has led many of the pivotal clinical trials of vaccines licensed in the
past several decades and has played a major role in their implementation. She graduated from the University of Iowa College of Medicine and completed her pediatric residency
and infectious disease fellowship at Northwestern University and her postdoctoral training in Immunology at Rush Medical School in Chicago, Illinois.
Dr. Edwards joined the Vanderbilt Vaccine Program in 1980 and directed it for many years. She has served on multiple CDC, NIH, FDA, WHO, and IDSA committees. She was the Chair of the Vaccines
and Related Biologic Products Advisory Committee of the FDA and has served on multiple vaccine safety and monitoring committees for industry and government. She directed
the NIH-funded Vaccine Treatment and Evaluation Unit at Vanderbilt for many years.
In 2006, she received the IDSA Mentor Award for her exceptional mentoring and in 2014
received the Maureen Andrews Mentoring Award from the Society for Pediatric Research. In 2008 she was elected to the Institute of Medicine of the National Academy of Sciences,
in 2018 she was awarded the Maxwell Finland award for Scientific Accomplishments, in 2019 she received the Frank Morriss Leadership Award in Pediatrics, and in 2020 she was
awarded the Howland Award for her accomplishments in Pediatrics by the American Pediatric Society.
She is currently active in assessing the safety and effectiveness of COVID vaccines and monoclonal antibodies and in mentoring the next generation of vaccine scientists.
|
|
ELISA GREENE, PharmD, BCACP
Director
Elisa Greene, PharmD, BCACP is an Associate Professor of Pharmacy Practice at Belmont University College of Pharmacy where she practices in the primary care setting.
She earned her B.S. in Biomedical Sciences from Auburn University and Doctor of Pharmacy degree from the University of Tennessee Health Science Center.
She then completed a Pharmacy Practice residency with an emphasis in Ambulatory Care, and concurrently completed a Teaching Certificate program at Palm Beach Atlantic University.
In her current role, she teaches in the classroom throughout the curriculum in Pathophysiology & Therapeutics and Pharmaceutical Care sequences – training front-line immunizers
and guiding pharmacy students to understand the complexities, risks, and potential benefits of properly utilized medication therapy – including vaccinations. Additionally,
she provides medication management and other clinical pharmacy services and experiential student training at Siloam Health. Siloam is a faith-based nonprofit that provides
medical care for the underserved, community health for marginalized immigrant populations, and student education for the next generation of health care providers.
Dr. Greene’s practice and research interests include cross-cultural care provision, medication therapy-oriented quality improvement, and interdisciplinary collaboration with
medical interpreters. She is a member of the 2021-2023 cohort of the Lilly Faculty Fellows Program, is actively engaged in professional organizations, regularly serves as a
reviewer for scholarly works, and has numerous publications in pharmacy and medical literature. She was recognized by the Tennessee Pharmacists Association with its
Distinguished Young Pharmacist Award, was a finalist in the Frist Foundation Salute to Excellence Team Building Award and was selected as a participant in the
Child Family Health International Global Health Immersion Program in Tropical Medicine and Community Health.
|
|
JAMIE SWIFT, MSN-IPC, RN, CIC, FAPIC
Director
Jamie Swift is the Assistant Vice President of Infection Prevention and the Chief Infection Prevention Officer for Ballad Health. In this role, Swift is responsible for managing
the Infection Prevention department for the health system, which encompasses 21 hospitals across Northeast Tennessee and Southwest Virginia.
Before being appointed to her current position, Swift served as the Infection Prevention Director for Mountain States Health Alliance, a 14-hospital health system.
In February of 2018, Mountain States merged with Wellmont Health System to become Ballad Health, and Swift was chosen to lead the newly formed organization’s Infection Prevention department.
Prior to transitioning to the acute care hospital setting, Swift worked 11 years with the Tennessee Department of Health, 9 of which she served as the Director of
Communicable and Environmental Disease Services for the Northeast Tennessee Region. In 2017, Swift was also one of only seven recipients of the APIC Infection Prevention Hero Award.
Swift received this prestigious recognition for her work done in establishing the first hospital in Tennessee to become a highly infectious disease assessment hospital in the
Highly Infectious Disease Treatment Network. Most recently, she has been instrumental in leading the Ballad Health response to the COVID-19 pandemic.
Swift earned her Master of Science in Nursing degree, with a specialization in Infection Prevention and Control, in 2021. She earned her bachelor’s degree in Nursing as well
as her Certification in Executive Leadership from Milligan University in Tennessee. She currently holds Board Certification in Infection Control as well as a Fellowship with APIC.
|
|
CAROLYN W. WENZEL, JD
Director
Carolyn Wenzel is a partner of the law firm of Sherrard, Roe, Voigt & Harbison, PLC in Nashville, Tennessee.
She recently completed a term as chair of the Electric Power Board (Nashville Electric Service),
the five-member board of one of the 12 largest public electric utilities in the United States.
In the community, Carolyn is also General Counsel on the Executive Committee for the Nashville
Area Chamber of Commerce and a current board member on the Nashville Symphony, a Trustee of the Tennessee Annual Conference of the United Methodist Church,
and a member of the Studio Bank Founders’ Advisory Board. She is a member of the Leadership Nashville class of 2016.
Carolyn is a tax attorney with a 25+ year career in private practice in Tennessee and Michigan.
She represents local and national companies in state and local tax (property tax, sales tax, franchise and excise tax,
and business tax) cases. Her practice includes advising individuals, families, and small businesses in estate planning,
business succession and estate administration. In addition, she regularly counsels nonprofit entities and tax-exempt organizations,
including public charities, private foundations, trade and professional associations, and religious and educational organizations
in the areas of business planning, governance, regulatory compliance, tax exemption qualification, and litigation.
Carolyn has a Master of Science in Taxation from Grand Valley State University and a dual degree Juris Doctor and Master of Arts in Philosophy
from the University of Kansas. She graduated Hollins College with a degree in French, which included living and studying in Paris for the calendar year 1987.
|
|
| This page was updated on August 29, 2022. |
| This page was reviewed on August 29, 2022. |
|
|
|
|
ACIP Recommendations
Vaccine Information Statements 
SUPPORT IAC
